Profile
Michael Andreeff is a Professor at The University of Texas M.D.
Anderson Cancer Center, where he currently works.
He previously worked as a Director at Oncoceutics, Inc. Dr. Andreeff holds a doctorate degree from Ruprecht-Karls-Universität Heidelberg.
Michael Andreeff active positions
| Companies | Position | Start |
|---|---|---|
The University of Texas M.D. Anderson Cancer Center
The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services Provides cancer patient care, research and prevention for cancer | Corporate Officer/Principal | - |
Former positions of Michael Andreeff
| Companies | Position | End |
|---|---|---|
Oncoceutics, Inc.
Oncoceutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops imipridones for cancer treatment | Director/Board Member | - |
Training of Michael Andreeff
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
The University of Texas M.D. Anderson Cancer Center
The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services Provides cancer patient care, research and prevention for cancer | Consumer Services |
Ruprecht-Karls-Universität Heidelberg
Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncoceutics, Inc.
Oncoceutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops imipridones for cancer treatment | Health Technology |
- Stock Market
- Insiders
- Michael Andreeff
















